Status:
COMPLETED
Exercise Intervention in Breast Cancer Patients With Treatment-Induced Arthralgia
Lead Sponsor:
Roswell Park Cancer Institute
Conditions:
Breast Cancer
Arthralgia
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
This is a pilot study of a specifically designed exercise intervention developed for breast cancer patients with aromatase-inhibitor related joint pain.
Eligibility Criteria
Inclusion
- Post menopausal women with a history of estrogen positive breast cancer who are receiving aromatase inhibitors for at least one month.
- Patients must complain of mild to moderate arthralgia.
- Ability to understand and sign informed consent.
- Patients meet criteria for low to moderate risk for moderate exercise based oon the ACSM guidelines.
Exclusion
- Inability to comply with study requirements.
- Metastatic breast cancer.
- Patients with orthopedic or neuromuscular disorders that preclude participation in exercise.
- Rheumatoid arthritis.
- History of MI, angina or congestive heart failure.
- Pregnant or lactating females.
- Patients that are high risk for moderate exercise based on ACSM risk classification.
- Patients who exceed minimal physical activity recommendations from the US Surgeon General's Report: Accumulation of 30 minutes or more of moderate physical activity on most days of the week.
- Morbidly obese with BMI ≥ 40
Key Trial Info
Start Date :
March 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
27 Patients enrolled
Trial Details
Trial ID
NCT01236417
Start Date
March 1 2010
Last Update
April 13 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Roswell Park Cancer Institute
Buffalo, New York, United States, 14263